Farjah Algahtani: Stroke Incidence and Risk Factors in Saudi Patients with Sickle Cell Disease
Farjah Algahtani, Director of Epidemiology and Public Health Research at King Saud University, Professor Of Hematology, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in British Journal of Haematology, adding:
“As we mark Sickle Cell Disease Awareness Month, I am especially proud to contribute to improving our understanding of this complex disease and its complications in our Saudi population.
There is still much to learn about the unique phenotypes, risk factors, and long-term outcomes of patients with SCD.
I am sharing the results of our longitudinal study, ‘Stroke Incidence and Phenotype in Saudi Patients with Sickle Cell Disease,’ published in the British Journal of Haematology.
In this study of 195 Saudi patients with SCD, followed for a median of 13.5 years, we explored the incidence, phenotype, and laboratory correlates of stroke. Our findings highlight an important age-related pattern of stroke and the significant burden of both overt stroke and silent cerebral infarction.
We also found that higher LDH was associated with increased ischaemic stroke risk, while HbF showed a potentially protective effect.
I would like to extend my sincere thanks and appreciation to all the authors and collaborators for their valuable contributions and dedication to this important work.
Most importantly, a special thank you to our patients and their families, whose participation and trust made this research possible.
I hope that through continued research, collaboration, and awareness, we can contribute more to improving the lives and outcomes of people living with sickle cell disease.
Proud to be part of this important work and to collaborate with my colleagues at King Saud University.”
Title: Stroke incidence and phenotype in Saudi patients with sickle cell disease: A longitudinal cohort study
Authors: Mohammed Al-Agha, Fahad Albadr, Aamer Aleem, Farjah H. Algahtani, Ali Al-Shehri, Fahad Bashiri, Abdulrahman Alsultan

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments
-
Nov 16, 2026, 12:44Stefan Prendić: How Intronic Variants Affect Rh Blood Group Antigen Expression
-
Nov 16, 2026, 12:26Samwel Mikaye: Understanding Warfarin and Its Clinical Management
-
Nov 16, 2026, 12:14Sophia Delicou: Ensuring Lifelong Health Beyond Stem Cell Transplantation
-
Nov 16, 2026, 12:06Edward Lee Carter: Has PEPPER Changed the Role of Aspirin in Arthroplasty VTE Prophylaxis?
-
Nov 16, 2026, 11:53Eduardo Ortiz Bello: The Endothelium in Hemostasis and Microcirculation
-
Nov 16, 2026, 11:51Phil Spinella: Advancing Transfusion Medicine Through Collaboration